Catalyst Wire Dossier Catalyst Wire Dossier

Posiformin 2% Eye Ointment

· Ursapharm Arzneimittel GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Posiformin 2% Eye Ointment, covering 2011-05-20 to 2011-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Posiformin 2 % Eye Ointment in the Treatment of Blepharitis [Phase 4]

See pricing